1. | | Completed | A "Pre-Enrollment" Protocol for HIV-Infected Adolescents Condition: HIV Infections |
2. | | Completed | (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC Condition: HIV Infections |
3. | | Suspended | 10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma |
4. | | Completed | 12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes. Condition: Diabetes, type I |
5. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
6. | | Recruiting | A 14-day study of Racivir when used in combination in HIV-Infected Males Condition: HIV Infections |
7. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
8. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas Conditions: adult solid tumor; Leukemia; Lymphoma |
9. | | Recruiting | 17-DMAG to Treat Patients with Solid Tumors or Lymphomas Conditions: Neoplasms; Lymphoma |
10. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma Condition: Cancer |
11. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Conditions: adult Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; adult non-Hodgkin's lymphoma; adult solid tumor; Cutaneous T-Cell Lymphoma; ... |
12. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors Conditions: Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Neuroblastoma; Osteosarcoma |
13. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia Conditions: unspecified childhood solid tumor, protocol specific; recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia; ... |
14. | | Recruiting | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific |
15. | | Recruiting | A 24 Week Study of Daily Oral Investigational Drug vs Placebo in Patients with Asthma Condition: Asthma |
16. | | Completed | A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients with AIDS Conditions: Cryptosporidiosis; HIV Infections |
17. | | No longer recruiting | 3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy Condition: Rheumatoid Arthritis |
18. | | No longer recruiting | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease |
19. | | Recruiting | 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia |
20. | | Recruiting | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ... |
21. | | Completed | 3TC (Lamivudine; GR109714X) Open-Label Program Condition: HIV Infections |
22. | | No longer recruiting | 4'-Iodo-4'-deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis Condition: primary systemic amyloidosis |
23. | | Recruiting | 4-Day-A-Week Treatment Plan for HIV Infected Adolescents Condition: HIV Infections |
24. | | Completed | A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients Condition: Multiple Sclerosis |
25. | | Recruiting | 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection Condition: HIV Infections |
26. | | Completed | 506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents Conditions: refractory chronic lymphocytic leukemia; T-cell chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia |
27. | | No longer recruiting | 506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment Conditions: Leukemia; Lymphoma; Multiple Myeloma |
28. | | No longer recruiting | 506U78 in Treating Patients With Lymphoma Conditions: Leukemia; Lymphoma |
29. | | Suspended | 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia Conditions: recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ... |
30. | | No longer recruiting | 506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma Conditions: recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome |
31. | | No longer recruiting | 506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult T-cell leukemia/lymphoma; angioimmunoblastic T-cell lymphoma; ... |
32. | | No longer recruiting | 506U78 in Treating Patients With Refractory Hematologic Cancer Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia |
33. | | No longer recruiting | 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ... |
34. | | Recruiting | 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Conditions: recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma |
35. | | Completed | 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia Conditions: Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ... |
36. | | Completed | 8-Chloro-cyclic Adenosine Monophosphate in Treating Patients With Recurrent or Refractory Multiple Myeloma Conditions: stage II multiple myeloma; stage III multiple myeloma; stage I multiple myeloma; refractory plasma cell neoplasm |
37. | | Completed | ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past Condition: HIV Infections |
38. | | Recruiting | Acetyl-L-Carnitine for the Treatment of NRTI-Associated Peripheral Neuropathy Conditions: HIV Infections; Peripheral Nervous System Diseases |
39. | | No longer recruiting | Acitretin in Treating Patients With Skin Disease or Skin Cancer Conditions: actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ... |
40. | | Recruiting | Activation and Function of Eosinophils in Conditions with Blood or Tissue Eosinophilia Conditions: Asthma; Eosinophilia; Helminthiasis; Hypersensitivity; Parasitic Disease |
41. | | Completed | Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity Condition: HIV Infections |
42. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) Conditions: HIV Infections; Pregnancy |
43. | | Completed | Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of VaxSyn Recombinant gp160 (NOTE: Some Patients Receive Placebo) Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
44. | | Terminated | Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) Conditions: HIV Infections; Pregnancy; HIV Seronegativity |
45. | | No longer recruiting | Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation Conditions: Graft vs Host Disease; Multiple Myeloma |
46. | | No longer recruiting | Active Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines Conditions: B Cell Lymphoma; Follicular Lymphoma; Lymphoma |
47. | | Recruiting | Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients Condition: HIV Infections |
48. | | Completed | Acupuncture and Herbal Treatment of Chronic HIV Sinusitis Conditions: HIV Infections; Sinusitis |
49. | | Recruiting | Acupuncture and Moxa: A RCT for Chronic Diarrhea in HIV Patients Condition: HIV Infections |
50. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |